• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Prediction of antitumor activity of chemotherapeutic agent by measurement of telomerase activity and expression of human telomerase reverse transcriptase gene.

Research Project

Project/Area Number 12671253
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionIwate Medical University

Principal Investigator

TERASHIMA Masanori  Iwate Med. Univ., School of Medicine Dept. of Surgeryl, Assistant Professor, 医学部, 講師 (40197794)

Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2001: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2000: ¥2,500,000 (Direct Cost: ¥2,500,000)
Keywordstelomerase / gastric cancer / breast cancer / chemosensitivity test / telomerase reverse transcriptase / real-time RT-PCR / cell cycle
Research Abstract

In order to develop an assay for predicting sensitivity to anticancer drugs, we evaluated the telomerase activity and expression of human telomerase reverse transcriprase (hTERT) gene using human gastric and breast cancer cell lines.
Doxorubicin (DOX), 5-fluorouracil (5-FU), cis-platinum (CDDP) and irinotecane (CPT-11; SN-38) were added to the culture of human gastric and breast cancer cell lines (3 types each), and then cell number, cell cycle, telomerase activity and expression of hTERT mRNA were serially measured. In DOX, 5-FU and CDDP treated group, telomerase activity and expression of hTERT mRNA gradually decreased in accordance with antitumor effect. However, transient increase in telomerase activity and hTERT expression were observed 24 hr after drug treatment in CPT-11 treated group. There was no correlation between the changes in cell cycle and telomerase activity nor hTERT mRNA expression. There also was no relationship between antitumor activity and expression of human telomerase RNA subunit nor human telomerase protein p80.
Human gastric cancer cell line MKN-28 was transplanted to nude mouse and in vivo experiment was also carried out. Similar to the results obtained from in vitro experiment, gradual decrease in telomerase activity and hTERT mRNA expression were obtained after treatment by DOX, 5-FU and CDDP. On the contrary, transient increase in telomerase activity and hTERT mRNA expression were also observed by CPT-11 treatment.
From these results, hTERT is supposed to be the most important factor which regulate the telomerase activity. In most of anticancer drugs, telomerase activity and hTERT mRNA expression decreased in accordance with antitumor effect. However, transient increase was also observed in certain kind of anticancer drug. Therefore, we have to be careful to apply this assay system for clinical test.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Masanori Terashima: "Telomerase assay as a possible predictor of the response to anticancer chemotherapy"Anticancer Research. 20・1. 293-297 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masanori Terashima: "Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer"Anticancer Research. 22(in press). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 寺島雅典: "抗癌剤感受性試験の進歩 ATP法"組織培養工学. 26・4. 134-138 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 寺島雅典: "Real time PCRの臨床応用"血液・腫瘍科. 42・1. 78-85 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 稲葉亨, 寺島雅典: "胃癌の診断と治療、胃癌の発癌分子機構・病態、Bub1遺伝子"日本臨床. 59・4. 44-47 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masanori Terashima et al.: "Telomerase assay as a possible predictor of the response to anticancer chemotherapy"Anticancer Research. 20, 1. 293-297 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masanori Terashima et al.: "Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer"Anticancer Research. 22 (in press). (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masanori Terashima et al.: "Progress in chemosensitivity test ; ATP assay (in Japanese)"Tissue Culture Engineering. 26, 4. 134-138 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masanori Terashima et al.: "Clinical application of real-time PCR (in Japanese)"Hematology & Oncology. 42, 1. 78-85 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Toru Inaba, Masanori Terashima et al.: "Bub 1 gene (in Japanese)"Nippon-Rinsho. 59, 4. 44-47 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masanori Terashima: "Telomerase assay as a possible predictor of the response to anticancer chemotherapy"Anticancer Research. 20・1. 293-297 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Masanori Terashima: "Roles thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer"Anticancer Research. 22(in press). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] 寺島雅典: "抗癌剤感受性試験の進歩 ATP法"組織培養工学. 26・4. 134-138 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] 寺島雅典: "Real time PCRの臨床応用"血液・腫瘍科. 42・1. 78-85 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 稲葉 亨, 寺島雅典: "胃癌の診断と治療・胃癌の発癌分子機構・病態、Bub1遺伝子"日本臨床. 59・4. 44-47 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] MASANORI TERASHIMA: "Telomerase assay as a possible predictor of the response to anticancer chemotherapy"Anticancer Research. 20. 293-298 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi